# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015990
Filing Date
2023-05-05
Accepted
2023-05-05 07:39:41
Documents
82
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrk-20230331.htm iXBRL | 10-Q | 2499765
2 | RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER | exhibit311-rule13ax14a15dx.htm | EX-31.1 | 8711
3 | RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER | exhibit312-rule13ax14a15dx.htm | EX-31.2 | 8546
4 | SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER | exhibit321-section1350cert.htm | EX-32.1 | 4109
5 | SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER | exhibit322-section1350cert.htm | EX-32.2 | 3917
| Complete submission text file | 0001628280-23-015990.txt |  | 12106437

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20230331.xsd | EX-101.SCH | 55590
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20230331_cal.xml | EX-101.CAL | 82325
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20230331_def.xml | EX-101.DEF | 362101
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20230331_lab.xml | EX-101.LAB | 704580
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20230331_pre.xml | EX-101.PRE | 502120
76 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20230331_htm.xml | XML | 2913023

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 23891254
SIC: 2834 Pharmaceutical Preparations